Drug major Pfizer Inc. raised Wednesday its outlook for fiscal 2021 earnings and revenues following strong second quarter results that exceeded market estimates. According to the company, the upward revision in full-year outlook, for the second quarter in a row, reflects its updated expectations for contributions to 2021 performance from both BNT162b2, the Pfizer-BioNTech SE COVID-19 vaccine.
from RTT - Top Story https://ift.tt/3zY3rNh
via IFTTT
from RTT - Top Story https://ift.tt/3zY3rNh
via IFTTT
Comments
Post a Comment